Clinical trial
Duloxetine for Chronic Depression: a Double-blind Study
NCT00360724 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00360724 |
|---|---|
| Title | Duloxetine for Chronic Depression: a Double-blind Study |
| Official title | Duloxetine for Chronic Depression: a Double-blind Study |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dysthymic Disorder, Depressive Disorder NOS |
| Intervention type | Drug |
| Interventions | Duloxetine (Cymbalta) |
| Enrollment | 65 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2013 |
| First posted | Aug 7, 2006 |
| Last update posted | Aug 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: